Clinical Trial Update: Frameless Fractionated Stereotactic Radiation in Treating Patients With Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating frameless fractionated stereotactic radiation for brain metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Malignant Neoplasm in the Brain

Drugs mentioned

• frameless fractionated stereotactic radiation

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Metastatic Malignant Neoplasm in the Brain | Phase 2 | Status: COMPLETED